Viewing Study NCT00518895


Ignite Creation Date: 2025-12-24 @ 2:03 PM
Ignite Modification Date: 2025-12-27 @ 9:54 PM
Study NCT ID: NCT00518895
Status: COMPLETED
Last Update Posted: 2011-11-07
First Post: 2007-08-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
Sponsor: Genta Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module